Characterization of a novel metabolic strategy used by drug‐resistant tumor cells

Abstract
Acquired or inherent drug resistance is the major problem in achieving successful cancer treatment. However, the mechanism(s) of pleiotropic drug resistance remains obscure. We have identified and ch...
Funding Information
  • National Institutes of Health (RO1 GM62562, RO1 HL61346)
  • Natural Sciences and Engineering Research Council of Canada
  • National Institutes of Health (DK 56818)
  • U.S. Department of Energy